Intevac Announces Third Quarter 2020 Financial Results
Mon, October 26 2020
“Q3 revenues were aligned with our expectations, and with favorable product mix driving solid gross margins, our bottom-line results were better than forecast,” commented
($ Millions, except per share amounts) |
Q3 2020 |
Q3 2019 |
||||||||||||||
GAAP Results |
Non-GAAP Results |
GAAP Results |
Non-GAAP Results |
|||||||||||||
Net Revenues |
$ |
21.6 |
|
$ |
21.6 |
|
$ |
26.3 |
|
$ |
26.3 |
|
||||
Operating Loss |
$ |
(0.1 |
) |
$ |
(0.0 |
) |
$ |
(0.4 |
) |
$ |
(0.4 |
) |
||||
Net Loss |
$ |
(0.4 |
) |
$ |
(0.3 |
) |
$ |
(0.5 |
) |
$ |
(0.5 |
) |
||||
Net Loss per Share |
$ |
(0.02 |
) |
$ |
(0.01 |
) |
$ |
(0.02 |
) |
$ |
(0.02 |
) |
||||
|
Nine Months Ended |
Nine Months Ended |
||||||||||||||
|
|
|||||||||||||||
GAAP Results |
Non-GAAP Results |
GAAP Results |
Non-GAAP Results |
|||||||||||||
Net Revenues |
$ |
69.2 |
|
$ |
69.2 |
|
$ |
73.4 |
|
$ |
73.4 |
|
||||
Operating Income (Loss) |
$ |
0.9 |
|
$ |
1.0 |
|
$ |
(3.4 |
) |
$ |
(3.4 |
) |
||||
Net Income (Loss) |
$ |
(0.1 |
) |
$ |
0.0 |
|
$ |
(4.1 |
) |
$ |
(4.0 |
) |
||||
Net Income (Loss) per Share |
$ |
(0.00 |
) |
$ |
0.00 |
|
$ |
(0.18 |
) |
$ |
(0.18 |
) |
||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) restructuring charges; and (2) changes in fair value of contingent consideration liabilities associated with business combinations. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section. |
Third Quarter 2020 Summary
The net loss for the quarter was
Revenues were
TFE gross margin was 43.5% compared to 28.2% in the third quarter of 2019 and 36.4% in the second quarter of 2020. The improvement compared to both periods reflected more favorable product mix. Photonics gross margin was 42.8% compared to 43.1% in the third quarter of 2019 and 43.9% in the second quarter of 2020. Consolidated gross margin was 43.1%, compared to 33.4% in the third quarter of 2019 and 39.6% in the second quarter of 2020.
R&D and SG&A expenses were
Order backlog totaled
The Company ended the quarter with
First Nine Months 2020 Summary
The net loss was
Revenues were
TFE gross margin was 40.2%, an improvement compared to 32.4% in the first nine months of 2019, as a result of more favorable product mix. Photonics gross margin was 43.2% compared to 34.9% in the first nine months of 2019. The improvement from the first nine months of 2019 was primarily due to higher revenue levels and improved margins on both product sales and research and development contracts. Consolidated gross margin was 41.7%, compared to 33.2% in the first nine months of 2019.
R&D and SG&A expenses were
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the Company’s operating and financial performance in light of business objectives and for planning purposes. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.
Conference Call Information
The Company will discuss its financial results and outlook in a conference call today at
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean®, INTEVAC MATRIX®, INTEVAC VERTEX®, ENERGi®, Diamond Dog®, DiamondClad®, VERTEX Marathon®, and VERTEX Spectra® are registered trademarks of
Safe Harbor Statement
This press release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”).
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except per share amounts) |
||||||||||
|
Three months ended |
Nine months ended |
||||||||
|
|
|
|
|
|
|||||
Net revenues |
|
|
|
|
|
|||||
TFE |
$ |
9,367 |
$ |
17,116 |
|
$ |
33,925 |
$ |
49,325 |
|
Photonics |
|
12,198 |
|
9,183 |
|
|
35,323 |
|
24,116 |
|
Total net revenues |
|
21,565 |
|
26,299 |
|
|
69,248 |
|
73,441 |
|
|
|
|
|
|
|
|||||
Gross profit |
|
9,300 |
|
8,778 |
|
|
28,876 |
|
24,375 |
|
Gross margin |
|
|
|
|
|
|||||
TFE |
|
43.5% |
|
28.2% |
|
|
40.2% |
|
32.4% |
|
Photonics |
|
42.8% |
|
43.1% |
|
|
43.2% |
|
34.9% |
|
Consolidated |
|
43.1% |
|
33.4% |
|
|
41.7% |
|
33.2% |
|
|
|
|
|
|
|
|||||
Operating expenses |
|
|
|
|
|
|||||
Research and development |
|
3,603 |
|
3,596 |
|
|
10,594 |
|
11,013 |
|
Selling, general and administrative |
|
5,845 |
|
5,615 |
|
|
17,426 |
|
16,720 |
|
Total operating expenses |
|
9,448 |
|
9,211 |
|
|
28,020 |
|
27,733 |
|
Total operating income (loss) |
|
(148) |
|
(433) |
|
|
856 |
|
(3,358) |
|
|
|
|
|
|
|
|||||
Operating income (loss) |
|
|
|
|
|
|||||
TFE |
|
(1,661) |
|
(1,542) |
|
|
(4,366) |
|
(3,434) |
|
Photonics |
|
3,032 |
|
2,268 |
|
|
9,480 |
|
3,114 |
|
Corporate |
|
(1,519) |
|
(1,159) |
|
|
(4,258) |
|
(3,038) |
|
Total operating income (loss) |
|
(148) |
|
(433) |
|
|
856 |
|
(3,358) |
|
|
|
|
|
|
|
|||||
Interest income and other income (expense), net |
|
8 |
|
126 |
|
|
212 |
|
448 |
|
Net income (loss) before provision for income taxes |
|
(140) |
|
(307) |
|
|
1,068 |
|
(2,910) |
|
Provision for income taxes |
|
217 |
|
173 |
|
|
1,125 |
|
1,144 |
|
Net loss |
$ |
(357) |
$ |
(480) |
|
$ |
(57) |
$ |
(4,054) |
|
|
|
|
|
|
|
|||||
Net loss per share |
|
|
|
|
|
|||||
Basic and Diluted |
$ |
(0.02) |
$ |
(0.02) |
|
$ |
(0.00) |
$ |
(0.18) |
|
|
|
|
|
|
|
|||||
Weighted average common shares outstanding |
|
|
|
|
|
|||||
Basic and Diluted |
|
23,771 |
|
23,130 |
|
|
23,605 |
|
22,992 |
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|||
|
(Unaudited) |
|
(see Note) |
|||
ASSETS |
|
|
|
|||
|
|
|
|
|||
Current assets |
|
|
|
|||
Cash, cash equivalents and short-term investments |
$ |
45,587 |
|
$ |
36,487 |
|
Accounts receivable, net |
|
23,221 |
|
|
28,619 |
|
Inventories |
|
23,638 |
|
|
24,907 |
|
Prepaid expenses and other current assets |
|
2,031 |
|
|
1,504 |
|
Total current assets |
|
94,477 |
|
|
91,517 |
|
|
|
|
|
|||
Long-term investments |
|
3,074 |
|
|
5,537 |
|
Restricted cash |
|
787 |
|
|
787 |
|
Property, plant and equipment, net |
|
11,552 |
|
|
11,598 |
|
Operating lease right-of-use assets |
|
8,739 |
|
|
10,279 |
|
Intangible assets, net |
|
4 |
|
|
274 |
|
Other long-term assets |
|
5,736 |
|
|
6,330 |
|
Total assets |
$ |
124,369 |
|
$ |
126,322 |
|
|
|
|
|
|||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|||
|
|
|
|
|||
Current liabilities |
|
|
|
|||
Current operating lease liabilities |
$ |
2,776 |
|
$ |
2,524 |
|
Accounts payable |
|
4,463 |
|
|
4,199 |
|
Accrued payroll and related liabilities |
|
6,478 |
|
|
6,488 |
|
Other accrued liabilities |
|
2,289 |
|
|
3,593 |
|
Customer advances |
|
1,051 |
|
|
4,007 |
|
Total current liabilities |
|
17,057 |
|
|
20,811 |
|
|
|
|
|
|||
Non-current liabilities |
|
|
|
|||
Non-current operating lease liabilities |
|
7,516 |
|
|
9,532 |
|
Other long-term liabilities |
|
688 |
|
|
186 |
|
Total non-current liabilities |
|
8,204 |
|
|
9,718 |
|
|
|
|
|
|||
Stockholders’ equity |
|
|
|
|||
Common stock ( |
|
24 |
|
|
23 |
|
Additional paid-in capital |
|
191,976 |
|
|
188,290 |
|
|
|
(29,551) |
|
|
(29,158) |
|
Accumulated other comprehensive income |
|
502 |
|
|
424 |
|
Accumulated deficit |
|
(63,843) |
|
|
(63,786) |
|
Total stockholders’ equity |
|
99,108 |
|
|
95,793 |
|
Total liabilities and stockholders’ equity |
$ |
124,369 |
|
$ |
126,322 |
|
Note: Amounts as of |
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (Unaudited, in thousands, except per share amounts) |
||||||||||||
|
|
|
||||||||||
|
Three months ended |
|
Nine months ended |
|||||||||
|
|
|
|
|
|
|||||||
Non-GAAP Income (Loss) from Operations |
|
|
|
|
|
|||||||
Reported operating income (loss) (GAAP basis) |
$ |
(148) |
$ |
(433) |
|
$ |
856 |
$ |
(3,358) |
|||
Restructuring charges1 |
|
103 |
|
— |
|
|
103 |
|
— |
|||
Change in fair value of contingent consideration obligations2 |
|
— |
|
— |
|
|
— |
|
7 |
|||
Non-GAAP Operating Income (Loss) |
$ |
(45) |
$ |
(433) |
|
$ |
959 |
$ |
(3,351) |
|||
|
|
|
|
|
|
|||||||
Non-GAAP Net Income (Loss) |
|
|
|
|
|
|||||||
Reported net loss (GAAP basis) |
$ |
(357) |
$ |
(480) |
|
$ |
(57) |
$ |
(4,054) |
|||
Restructuring charges1 |
|
103 |
|
— |
|
|
103 |
|
— |
|||
Change in fair value of contingent consideration obligations2 |
|
— |
|
— |
|
|
— |
|
7 |
|||
Income tax effect of non-GAAP adjustments3 |
|
— |
|
— |
|
|
— |
|
— |
|||
Non-GAAP Net Income (Loss) |
$ |
(254) |
$ |
(480) |
|
$ |
46 |
$ |
(4,047) |
|||
|
|
|
|
|
|
|||||||
Non-GAAP Net Income (Loss) Per Diluted Share |
|
|
|
|
|
|||||||
Reported net loss per diluted share (GAAP basis) |
$ |
(0.02) |
$ |
(0.02) |
|
$ |
(0.00) |
$ |
(0.18) |
|||
Restructuring charges1 |
|
0.00 |
|
— |
|
|
0.00 |
|
— |
|||
Change in fair value of contingent consideration obligations2 |
|
— |
|
— |
|
|
— |
|
0.00 |
|||
Non-GAAP Net Income (Loss) Per Diluted Share |
$ |
(0.01) |
$ |
(0.02) |
|
$ |
0.00 |
$ |
(0.18) |
|||
Weighted average number of basic shares |
|
23,771 |
|
23,130 |
|
|
23,605 |
|
22,992 |
|||
Weighted average number of diluted shares |
|
23,771 |
|
23,130 |
|
|
24,049 |
|
22,992 |
|||
1Results for the three and nine months ended |
||||||||||||
2Results for nine months ended |
||||||||||||
3The amount represents the estimated income tax effect of the non-GAAP adjustments. The Company calculated the tax effect of non-GAAP adjustments by applying an applicable estimated jurisdictional tax rate to each specific non-GAAP item. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201026005041/en/
Chief Financial Officer
(408) 986-9888
Investor Relations
(530) 265-9899
Source: